Investigation of DEXA-C Anterior Cervical Interbody System
Start Date
2/22/2023
Completion Date
2/22/2027
Summary
FDA Cleared interbody product for the cervical spine, designed to match a patients DEXA scan for increase in fusion rate.
Detailed Description
The DEXA-C Cervical Interbody System is indicated for anterior cervical interbody fusion procedures in skeletally mature patients with degenerative disc disease (DDD) of the cervical spine with accompanying radicular symptoms at one or two contiguous levels from C2-T1. Device system is designed for use with supplemental fixation and autograft and/or allogenic bone graft composed of cancellous, cortical, and/or cortico-cancellous bone to facilitate fusion and is to be implanted via an open, anterior approach. The Dexa-C clinical study will collect data on those patients who have been treated with Dexa-C Anterior Cervical Interbody System to allow for a better understanding of outcomes associated with it.
Eligibility Criteria
Age Range: 18 years to No maximum
Interventions
DEXA-C Cervical Interbody System
Conditions
Locations
UCI Center for Clinical Research
Orange, California 92868
United States
Orthopaedic Institute of Western KY
Paducah, Kentucky 42003
United States
Koga Neurosurgery
Covington, Louisiana 70433
United States
Optima Orthopedics
Oklahoma City, Oklahoma 73159
United States